CARES Systems Bring HIV Monitoring To A Higher Level Of Automation

CARES Solutions Men in lab

By focusing on innovative, yet affordable solutions for HIV monitoring, Beckman Coulter supports the UNAIDS 90-90-90 target to ensure that by the year 2020, 90% of people living with HIV will know their HIV status, 90% of people with diagnosed HIV infection will receive sustained antiretroviral therapy, and 90% of all people receiving antiretroviral therapy will have viral suppression.1

Putting The Power of Science Where It’s needed Most

Drawing from our history as leading biomedical life science companies, we’ve collaborated with healthcare leaders to develop breakthrough HIV monitoring solutions that contribute directly to the treatment process.

Your mission for timely HIV monitoring impacting treatment decisions in regions hardest hit by the disease, is what drives Beckman Coulter. At Beckman Coulter, we’re bringing a world of CARES to a world in need.

HIV Patient Management Solutions

By providing innovative solutions, Beckman Coulter’s CARES Systems brings monitoring of CD4+ lymphocytes and viral load levels to a higher level of automation.

To successfully optimize your laboratory, nothing is more important than choosing the right partner. When you select Beckman Coulter, you get a proactive collaborator to create innovative solutions for your everyday challenges. It‘s a partnership that will provide the tools to improve the quality, workflow and operational efficiency of your laboratory, every step of the way.

 AQUIOS CL Load and Go Flow Cytometer


Download Brochure

*Photos courtesy of Dr. Charles Kiyaga

1. 90-90-90 An ambitious treatment target to help end the AIDS epidemic - UNAIDS / JC2684 (English original, October 2014)



Please keep me informed about Beckman Coulter webinars, products, goods, and services, including products, goods, or services from our related companies.

By submitting this form I confirm that I have reviewed and agree with the Privacy Policy and Terms of Use. I also understand my privacy choices as they pertain to my personal data as provided in the Privacy Policy under “Your Privacy Choices”.

WHO Prequalification of CD4 Instrument

The AQUIOS CL flow cytometer has been accepted by the World Health Organization (WHO) Prequalification of In Vitro Diagnostics Programme. It can now be used specifically for the immunologic assessment of patients having, or suspected of having, immune deficiency.

Freeing up Your Skilled Operators

Many traditional flow-cytometry systems require either manual or semi-automated preparation of samples, manual creation of work lists, manual data review, and manual tabulation of numerical data.

The PLG Breakthrough from South Africa

Monitoring CD4 lymphocyte counts is essential in providing critical information that impacts patient care.


Minimizing the Potential for User Error

Laboratory standards and regulations set forth by governmental bodies such as the Centers for Disease Control and Prevention (CDC) help to define and standardize the procedures that laboratories employ.